These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16333870)

  • 41. This means war.
    Nat Biotechnol; 2008 Sep; 26(9):954. PubMed ID: 18779784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Principles, property rights, and profits: historical reflections on university/industry relations.
    Kevles DJ
    Account Res; 2001; 8(4):293-307. PubMed ID: 12481797
    [No Abstract]   [Full Text] [Related]  

  • 43. A blueprint for biotech's blues.
    Nat Biotechnol; 2009 Aug; 27(8):675. PubMed ID: 19668152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Do biomaterials really mean business?
    Waltz E
    Nat Biotechnol; 2008 Aug; 26(8):851-3. PubMed ID: 18688229
    [No Abstract]   [Full Text] [Related]  

  • 45. What's hot in biotech employment.
    Hochberg SP
    Nat Biotechnol; 2001 Apr; 19(4):389. PubMed ID: 11283604
    [No Abstract]   [Full Text] [Related]  

  • 46. Australian biotech suffers growing pains.
    O'Neill G
    Nat Biotechnol; 2005 Apr; 23(4):401-2. PubMed ID: 15815652
    [No Abstract]   [Full Text] [Related]  

  • 47. OECD says industrial biotech not realizing potential.
    Niiler E
    Nat Biotechnol; 2001 Jun; 19(6):493-4. PubMed ID: 11385413
    [No Abstract]   [Full Text] [Related]  

  • 48. Support for biotechnology.
    Hambleton P
    J Chem Technol Biotechnol; 1990; 47(2):171-7. PubMed ID: 1366406
    [No Abstract]   [Full Text] [Related]  

  • 49. Materials exchange deal meager boost to India's biotech.
    Jayaraman KS
    Nat Biotechnol; 2005 Sep; 23(9):1031. PubMed ID: 16151380
    [No Abstract]   [Full Text] [Related]  

  • 50. Fertile grounds.
    Russo G
    Nature; 2009 Oct; 461(7268):1308-9. PubMed ID: 19998548
    [No Abstract]   [Full Text] [Related]  

  • 51. Open source and biotech.
    Bains W
    Nat Biotechnol; 2005 Sep; 23(9):1046. PubMed ID: 16151387
    [No Abstract]   [Full Text] [Related]  

  • 52. Perspective: Biotech funding trends: Insights from entrepreneurs and investors.
    Gruber AC
    Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BIO 2006 Annual International Convention. The expanding biotech industry of France.
    Zarkowska T
    IDrugs; 2006 Jun; 9(6):383-5. PubMed ID: 16752302
    [No Abstract]   [Full Text] [Related]  

  • 54. Universities could gain from backing biotech.
    Kamb A
    Nature; 2003 Mar; 422(6928):113. PubMed ID: 12634753
    [No Abstract]   [Full Text] [Related]  

  • 55. Tough times set to continue for US biotech start-ups.
    Lehrman S
    Nature; 1999 Jan; 397(6716):191. PubMed ID: 9930684
    [No Abstract]   [Full Text] [Related]  

  • 56. Putting a price on biotechnology.
    Stewart JJ; Allison PN; Johnson RS
    Nat Biotechnol; 2001 Sep; 19(9):813-7. PubMed ID: 11533634
    [No Abstract]   [Full Text] [Related]  

  • 57. Fickle financing climate continues.
    Mitchell P
    Nat Biotechnol; 2001 Aug; 19(8):695-6. PubMed ID: 11479542
    [No Abstract]   [Full Text] [Related]  

  • 58. Today's biotech industry in India.
    Suresh N
    Biotechnol J; 2009 Mar; 4(3):291-4. PubMed ID: 19296434
    [No Abstract]   [Full Text] [Related]  

  • 59. Benefits of biotech clusters questioned.
    Sheridan C
    Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
    [No Abstract]   [Full Text] [Related]  

  • 60. Public biotech 2000--the numbers.
    Lähteenmäki R; Fletcher L
    Nat Biotechnol; 2001 May; 19(5):407-12. PubMed ID: 11329000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.